News
Important Only
U.S. STOCKS ON THE MOVE-Eli Lilly, Palantir, Tesla
The Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsletter: https://refini.tv/3dKUyB8The S&P 500 and Nasdaq were poised to kick off November on firmer ground on Monday, driven by optimism around AI demand and a U.S.-China trade truce, while Kenvue shares soared after Kim...Reuters
Mon, Nov 3
LIVE MARKETS-Supreme Court tariff case may bring market volatility
US equity indexes mixed, Nasdaq up 0.7%, Dow dipsCons disc leads S&P 500 sector gains, materials weakestSTOXX 600 up 0.1%Dollar dips: gold, crude gain; bitcoin down >2%US 10-Year Treasury yield climbs to 4.11%Welcome to the home for real-time coverage of markets brought to you by Reuters repo...Reuters
Mon, Nov 3
Kimberly-Clark bets $40 billion for Kenvue despite Tylenol controversy
Kenvue faces litigation over Tylenol and baby powder productsKimberly-Clark shares down 13%, Kenvue up as much as 19.6%Deal at 46.2% premium to Kenvue's last close priceBy Juveria Tabassum and Sriparna Roy Nov 3 (Reuters) - Kimberly-Clark is laying down $40 billion to buy Kenvue in a massive...Reuters
Mon, Nov 3
BioCryst Pharmaceuticals down after quarterly revenue miss
Shares of drugmaker BioCryst Pharmaceuticals BCRX.O down ~ 4% at $7.03 Posts Q3 revenue of $159.4 million, missing analysts' estimate of $163 million- data compiled by LSEG BCRX narrows 2025 revenue forecast for its skin disease drug orladeyo to between $590 million and $600 million from $580 m...Reuters
Mon, Nov 3
DT Midstream gets 'buy' rating as Jefferies starts coverage
Brokerage Jefferies starts coverage of pipeline operator DT Midstream DTM.N with "buy" rating and price target of $125PT represents upside of 14.1% to stock's last closeShares are up 1.2% at $110.7Brokerage says it expects co to grow at ~9% CAGR through 2030, driven by expansion in the M...Reuters
Mon, Nov 3
Tesla rises ahead of upcoming key shareholder vote
Shares of Tesla TSLA.O rise 2.2% to $466.32, hitting its highest level in 10 months, on Monday ahead of an upcoming key shareholder meeting that could determine CEO Elon Musk's $1 trillion pay planTSLA hit its highest since Dec. 18 and is on track for the second straight session of gainsTSLA wil...Reuters
Mon, Nov 3
Boqii Holding Ltd. Announces $4.2 Million Registered Direct Offering
SHANGHAI, Nov. 4, 2025 /PRNewswire/ -- Boqii Holding Ltd. (NYSE: BQ) (the "Company"), today announced that it has entered into a definitive agreement with certain investors for the purchase and sale of an aggregate of 1,500,000 of the Company's Class A ordinary share, par value $0.16 per s...PR Newswire
Mon, Nov 3
LIVE MARKETS-Shutdown drags on, but Goldman sees light at mid-November
US equity indexes mixed, Nasdaq up 0.5%, Dow dipsCons disc leads S&P 500 sector gains, materials weakestSTOXX 600 up 0.1%Dollar little changed, gold edges up; crude gains; bitcoin down >3%US 10-Year Treasury yield climbs to 4.12%Welcome to the home for real-time coverage of markets brought to...Reuters
Mon, Nov 3
US STOCKS-S&P 500, Nasdaq gain after Amazon-OpenAI deal; Kenvue jumps after buyout
Indexes: Dow down 0.3%, S&P 500 up 0.2%, Nasdaq up 0.6%Kimberly-Clark to acquire Kenvue for about $48.7 bln Iren jumps after $9.7 bln contract with MicrosoftU.S. manufacturing activity contracts in OctoberBy Twesha Dikshit and Purvi Agarwal Nov 3 2025 - The S&P 500 and Nasdaq edged higher...Reuters
Mon, Nov 3
PREVIEW: Palantir scales fresh peak ahead of report
Shares of Palantir Technologies PLTR.O up 1.9% at $204.24 after hitting fresh record high on Mon as data analytics and AI firm due to report Q3 results after markets closeLast week, Nvidia NVDA.O and PLTR announced an AI deal that they said would help companies with logistics problems, such as when ...Reuters
Mon, Nov 3
London stocks dip at start of earnings-heavy, BoE rate verdict week
FTSE 100 down 0.2%, FTSE 250 falls 0.3%Bank of England rate decision on ThursdayBP, AstraZeneca among others to report earnings this weekFrasers, Vodafone down after rating downgrades Nov 3 (Reuters) - London's main stock indexes dipped on Monday, dragged down by materials and utilities s...Reuters
Mon, Nov 3
UBS initiates Solstice Advanced Materials with 'buy' rating
UBS initiates Solstice Advanced Materials SOLS.O with "buy" rating Sets PT at $62, which represents a 37.6% upside on stock's last closeShares of Solstice Advanced Materials fall nearly 1.5% to about $44.3 SOLS began trading as an independent company on Oct. 30, following its spin-of...Reuters
Mon, Nov 3
LIVE MARKETS-Truce, tokens, and tech: Jefferies unveils their S&P 500 moonshot
US equity indexes mixed, Nasdaq up 0.5%, Dow dipsCons disc leads S&P 500 sector gains, materials weakestSTOXX 600 flatDollar little changed, gold edges up; crude gains; bitcoin down >3%US 10-Year Treasury yield climbs to 4.11%Welcome to the home for real-time coverage of markets brought to yo...Reuters
Mon, Nov 3
Shares of copper miners fall after prices dip on strong US dollar
Shares of copper miners fall, tracking price of red metal MET/LBenchmark three-month copper CMCU3 on the London Metal Exchange down 0.2% at $10,891/metric tonne Prices fall as slowing manufacturing activity in top consumer China, along with stronger dollar weighing on sentiment, while mounting conce...Reuters
Mon, Nov 3
Cisco up after UBS raises PT
Shares of communications equipment maker Cisco CSCO.O up 1.6% at $74.24Brokerage UBS raises PT for CSCO to $88 from $74UBS expects FY26 revenue growth to exceed the 4% to 6% guide with continued strong growth in FY27, driven by AI strength as the company has secured over $2bln in AI orders from webs...Reuters
Mon, Nov 3
UniQure shares plummet as FDA says inadequate clinical data for Huntington's therapy
By Christy Santhosh Nov 3 (Reuters) - UniQure UQ1.F said the U.S. Food and Drug Administration no longer agreed that clinical data for the Dutch company's gene therapy for Huntington's disease may be adequate for a marketing application, triggering a 57% slump in its U.S.-listed shares.Mo...Reuters
Mon, Nov 3
AstraZeneca wins shareholder backing for NYSE listing in US pivot
Nov 3 (Reuters) - AstraZeneca AZN.L shareholders approved a direct listing of the drugmaker's shares on the New York Stock Exchange on Monday, giving it access to a deeper capital pool.The drugmaker said 99.36% of votes cast in a general meeting favoured the proposal. The company needed at least...Reuters
Mon, Nov 3
GLOBAL MARKETS-Stock indexes mostly gain after Amazon-OpenAI deal; dollar up slightly
Dow lower; S&P 500 and Nasdaq upDollar up slightly; some Fed officials express discomfort with rate cutsEarnings focus on tech firmsBy Caroline Valetkevitch and Amanda Cooper NEW YORK/LONDON, Nov 3 (Reuters) - Most major stock indexes were higher on Monday following news Amazon.com AMZN.O wil...Reuters
Mon, Nov 3
Eli Lilly rises after announcing plans to build $3 bln Dutch plant
Eli Lilly's LLY.N shares are up 2.7% to $886.07 after the drugmaker announced plans to build a $3 billion manufacturing plant in the Netherlands to expand production capacity of its weight-loss pill, among other medicinesLLY hit its highest level since April 30 and is on track for the third stra...Reuters
Mon, Nov 3
US shale producers SM Energy, Civitas to merge in $12.8 bln deal to boost Permian scale
Deal to create one of the largest independent U.S. oil producersCombined co to hold about 823,000 net acres across top U.S. shale basinsSM shares down 5.7%Analysts surprised at 5% premium for Civitas shareholdersBy Pooja Menon and Sumit Saha Nov 3 - SM Energy SM.N and Civitas Resources CIVI.N sa...Reuters
Mon, Nov 3
